Answers are grounded in this paper and cite their sources.
Examines PFAS levels and their influence on knee osteoarthritis and pain in a cohort, suggesting potential health risks.
Objective To examine whether concentrations of specific per‐ and polyfluoroalkyl substances (PFAS) and a mixture of PFAS relate to incident knee osteoarthritis (KOA) and knee pain progression. Methods Among a case‐cohort sample from the Osteoarthritis Initiative (n=1,878), we examined associations of serum concentrations of 8 PFAS with odds of developing over the subsequent 48 months (1) symptomatic KOA and (2) a clinically meaningful change in WOMAC knee pain score. We used weighted logistic regression to assess single PFAS (continuous and quartiles) and quantile g‐computation to assess the PFAS‐mixture in relation to our outcomes, accounting for sociodemographics. Results Fifty‐eight percent of participants were female with a mean age of 62 years and BMI of 28.6 kg/m 2 . Participants with higher perfluorooctanoic acid (continuous) had greater odds of incident symptomatic KOA [OR(95%CI) per interquartile‐range: 1.12(1.04‐1.21)]. Participants in the highest quartiles of perfluorononanoic acid (PFNA) had greater odds of incident symptomatic KOA [OR(95%CI): third quartile 1.63(1.29‐2.07); fourth quartile 1.55(1.19‐2.01)]. perfluorooctanoic acid may have a nonlinear relationship with the greatest chance of incident symptomatic KOA with serum concentrations between 5.19‐6.88 ng/mL [OR (95%CI): 1.55(1.21‐1.97)]. Participants with greater perfluorooctanoic acid and PFNA (continuous) had greater odds of knee pain progression [OR (95%CI) per interquartile‐range: perfluorooctanoic acid 1.10(1.03‐1.18) and PFNA 1.06(1.01‐1.11)]. Mixture models showed perfluorooctanoic acid and PFNA were among the PFAS with the strongest positive weights for both outcomes. Conclusion In a large cohort at risk for KOA, higher perfluorooctanoic acid and PFNA serum concentrations may be associated with a greater likelihood of symptomatic KOA incidence and knee pain progression.
No takes yet. Share an insight, caveat, or question.
Driban et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: